Sort
30,917 grants matching “tumor microenvironment”
3-Dimensional Retinal Organoid Platform for the Study of Retinoblastoma
$436,652Daniel Pelaez · University Of Miami School Of Medicine · R01 · FY2024 · CA
Surgical and Animal Core
$436,627Dai Fukumura · Massachusetts General Hospital · P01 · FY2016 · CA
Hypoxia-derived molecular MSI signatures to predict breast cancer outcome
$436,586Kristine Glunde · Johns Hopkins University · R01 · FY2020 · CA
Hypoxia-derived molecular MSI signatures to predict breast cancer outcome
$436,586Kristine Glunde · Johns Hopkins University · R01 · FY2018 · CA
Examining Sexual Dimorphisms: The Role of Estradiol Signaling in Modulating Immunity
$436,565Stephen R Hammes · University Of Rochester · R01 · FY2025 · HL
Pathways to Cancer Therapeutics
$436,475Susan E Waltz · University Of Cincinnati · T32 · FY2022 · CA
Brain Tumor Immunotherapy
$436,461Mark Gilbert · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
Engineered ECM platforms to analyze progression in high grade serous ovarian cancer
$436,446Pamela K Kreeger · University Of Wisconsin-Madison · R01 · FY2019 · CA
Targeting Metabolic Crosstalk in Pancreatic Cancer
$436,431Christopher J. Halbrook · University Of California-Irvine · R37 · FY2024 · CA
Engineered ECM platforms to analyze progression in high grade serous ovarian cancer
$436,391Pamela K Kreeger · University Of Wisconsin-Madison · R01 · FY2018 · CA
The role of the RNA demethylase FTO in metabolic reprogramming of renal cell carcinoma
$436,355Erinn B Rankin · Stanford University · R01 · FY2024 · CA
Targeting Polo-Like Kinase 1 in Prostate Cancer to Enhance Therapeutic Efficacy
$436,322Zhiguo Li · University Of Kentucky · R01 · FY2023 · CA
Role of the GPR4 Receptor in Intestinal Inflammation and Cancer
$436,300Li Yang · East Carolina University · R15 · FY2016 · DK
Role of Erbb3 kinase activity in colorectal tumorigenesis.
$436,262Zhenghe Wang · Case Western Reserve University · R01 · FY2025 · CA
TGF-Beta Suppression and Promotion of Mammary Carcinomas
$436,193Harold L Moses · Vanderbilt University · R01 · FY2007 · CA
Anti-Tumor Mechanisms of Intratumoral Stimulatory Dendritic Cells
$436,176Matthew F Krummel · University Of California, San Francisco · R01 · FY2021 · CA
Anti-Tumor Mechanisms of Intratumoral Stimulatory Dendritic Cells
$436,176Matthew F Krummel · University Of California, San Francisco · R01 · FY2020 · CA
Hepatic steatosis promotes liver metastasis
$436,171Nidhi Rohatgi · Washington University · R01 · FY2025 · CA
Tumor Cell Biology Training Program
$436,100Gay Miriam Crooks · University Of California Los Angeles · T32 · FY2016 · CA
Harnessing the power of exosomes for non-coding RNA delivery
$436,053Anil K Sood · University Of Tx Md Anderson Can Ctr · R35 · FY2023 · CA
LILRB modulates tumor microenvironment and promotes tumor progression
$436,037Shu-Hsia Chen · Methodist Hospital Research Institute · R01 · FY2021 · CA
LILRB modulates tumor microenvironment and promotes tumor progression
$436,037Shu-Hsia Chen · Methodist Hospital Research Institute · R01 · FY2020 · CA
Reprogramming the pancreatic tumor microenvironment with immunotherapy
$436,026Lei Zheng · Johns Hopkins University · R01 · FY2018 · CA
Developing new therapeutic strategies against head and neck cancer
$436,022Ratna B Ray · Saint Louis University · R01 · FY2022 · DE
Project 1: Overcoming resistance of B cell leukemia to CD19 CAR T Cells.
$435,992David Porter · University Of Pennsylvania · P01 · FY2017 · CA